Friday 6 November 2026
Export SXT’s income statement to Excel — free account
Sensient Technologies Corporation
SXT Basic Materials Specialty Chemicals
Sensient Technologies Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.6 billion, up 3.52% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +31.0%
- Free cash flow
- −90.9%
- Total debt
- +11.0%
Quarter to September 2026, against a year earlier
119.61
6.21
−4.94%
Follow SXT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
29.54 | 25.42 | 33.14 | 32.76 |
P/S ratio |
2.46 | 2.21 | 3.07 | 3.17 | |
P/FCF ratio |
103.29 | 166.97 | 1,164.96 | 0.00 | |
P/Operating CF |
89.04 | (268.48) | 107.74 | 136.79 | |
P/B ratio |
3.32 | 3.00 | 4.14 | 4.30 | |
Price to Tangible BV |
5.34 | 4.73 | 6.40 | 6.56 | |
EV/Sales |
2.88 | 2.65 | 3.50 | 3.60 | |
EV/EBITDA |
17.30 | 15.56 | 19.75 | 19.83 | |
EV/Operating CF |
36.31 | 35.60 | 48.26 | 52.42 | |
EV/FCF |
120.81 | 200.28 | 1,328.47 | (358.83) | |
Quick Ratio |
1.30 | 1.70 | 1.51 | 1.29 | |
Current Ratio |
4.10 | 5.01 | 4.39 | 3.97 | |
Net Debt/EBITDA |
12.61 | 8.86 | 7.92 | 8.43 | |
Debt/Assets |
31.62% | 33.56% | 32.22% | 31.92% | |
Debt/Equity |
0.59 | 0.63 | 0.61 | 0.61 | |
Asset Turnover |
0.76 | 0.76 | 0.74 | 0.75 | |
Operating CF/Net income |
1.75 | (0.31) | 0.94 | 0.84 | |
Capex/Depreciation |
(2.08) | (1.85) | (2.44) | (2.35) | |
Interest Coverage |
5.08 | 8.44 | 9.38 | 8.68 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
21.65% | 19.72% | 20.80% | 20.29% | |
Intangible Assets out of Total Assets |
0.20 | 0.20 | 0.19 | 0.18 | |
Share Based Compensation of Revenue |
0.85% | 0.87% | 1.21% | 0.96% | |
Graham Net Nets |
0.01 | 0.01 | 0.01 | 0.02 | |
Graham Number |
44.97 | 46.95 | 49.90 | 52.23 | |
Earnings Yield |
3.38% | 3.93% | 3.02% | 3.05% | |
Free Cash Flow Yield |
0.97% | 0.60% | 0.09% | (0.32%) | |
Revenue per Share |
9.32 | 10.30 | 10.91 | 10.76 | |
Operating CF per Share |
1.06 | (0.32) | 1.14 | 0.96 | |
Capex per Share |
(0.75) | (0.68) | (0.92) | (0.90) | |
Free Cash Flow per Share |
0.31 | (1.00) | 0.23 | 0.05 | |
Cash per Share |
0.87 | 0.91 | 0.73 | 1.01 | |
Shareholders Equity per Share |
28.26 | 28.82 | 29.75 | 30.38 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
28.26 | 28.82 | 29.75 | 30.38 | |
Free Cash Flow |
12.94 | (42.35) | 9.69 | 2.21 | |
Working Capital |
817.87 | 897.83 | 914.04 | 959.64 | |
Capital Expenditures |
(31.62) | (28.74) | (38.78) | (38.26) | |
Net Current Asset Value |
30.83 | 52.83 | 72.48 | 93.54 | |
EV/EBIT |
22.41 | 19.90 | 24.88 | 24.73 | |
Capex to Sales |
0.08 | 0.07 | 0.08 | 0.08 | |
Price to Operating Income |
19.16 | 16.59 | 21.82 | 21.79 | |
| Other line items | |||||
Average Receivables |
297.73 | 328.66 | 355.23 | 348.57 | |
Average Payables |
138.70 | 112.42 | 133.37 | 155.19 | |
Average Inventory |
639.26 | 639.97 | 669.34 | 722.41 | |
Average Assets |
2,133.97 | 2,190.13 | 2,287.83 | 2,342.69 | |
Average Common Equity |
1,127.25 | 1,156.96 | 1,208.52 | 1,233.44 |
Columns are period end dates · fundamentals updated 5 Nov 2026